NCT03293810View on ClinicalTrials.gov

Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

June 27, 2014

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Lipoprotein Lipase DeficiencyFamilial Hyperlipoproteinemia Type 1Familial Hyperchylomicronemia
Interventions
OTHER

Observational study

Post-Authorization Safety Study

Trial Locations (1)

13353

Interdisciplinary Metabolism Center, Lipid Out-Patient-Clinic, Lipid Apheresis, Charité, University of Berlin, Berlin

All Listed Sponsors
lead

UniQure Biopharma B.V.

INDUSTRY

NCT03293810 - Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients | Biotech Hunter | Biotech Hunter